Duration of COVID-19: Data from an Italian Cohort and Potential Role for Steroids

The diffusion of SARS-CoV-2, starting from China in December 2019, has led to a pandemic, reaching Italy in February 2020. Previous studies in Asia have shown that the median duration of SARS-CoV-2 viral shedding was approximately 12–20 days. We considered a cohort of patients recovered from COVID-1...

全面介绍

书目详细资料
Main Authors: Damiano D’Ardes, Michela Pontolillo, Lucia Esposito, Mara Masciarelli, Andrea Boccatonda, Ilaria Rossi, Marco Bucci, Maria Teresa Guagnano, Claudio Ucciferri, Francesca Santilli, Marta Di Nicola, Katia Falasca, Jacopo Vecchiet, Thomas Schael, Francesco Cipollone
格式: 文件
语言:English
出版: MDPI AG 2020-08-01
丛编:Microorganisms
主题:
在线阅读:https://www.mdpi.com/2076-2607/8/9/1327
实物特征
总结:The diffusion of SARS-CoV-2, starting from China in December 2019, has led to a pandemic, reaching Italy in February 2020. Previous studies in Asia have shown that the median duration of SARS-CoV-2 viral shedding was approximately 12–20 days. We considered a cohort of patients recovered from COVID-19 showing that the median disease duration between onset and end of COVID-19 symptoms was 27.5 days (interquartile range (IQR): 17.0–33.2) and that the median duration between onset of symptoms and microbiological healing, defined by two consecutive negative nasopharyngeal swabs, was 38 days (IQR: 31.7–50.2). A longer duration of COVID-19 with delayed clinical healing (symptom-free) occurred in patients presenting at admission a lower PaO<sub>2</sub>/FiO<sub>2</sub> ratio (<i>p</i> < 0.001), a more severe clinical presentation (<i>p</i> = 0.001) and a lower lymphocyte count (<i>p</i> = 0.035). Moreover, patients presenting at admission a lower PaO<sub>2</sub>/FiO<sub>2</sub> ratio and more severe disease showed longer viral shedding (<i>p</i> = 0.031 and <i>p</i> = 0.032, respectively). In addition, patients treated with corticosteroids had delayed clinical healing (<i>p</i> = 0.013).
ISSN:2076-2607